Results 301 to 310 of about 76,320 (330)

Naloxone Administration

AJN, American Journal of Nursing, 2016
openaire   +2 more sources

Pharmacokinetics and Pharmacodynamics of Naloxone

Academic Emergency Medicine, 2019
Brian M. Clemency, William Eggleston, Heather A. Lindstrom   +2 more
openaire   +3 more sources

Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose

International Journal of Pharmaceutics, 2021
Nazeer Hasan, Mohammad Imran, Prashant Kesharwani, Ramanujan Fellow   +2 more
exaly  

NALOXONE AND OPIATE ADDICTION

The Lancet, 1989
K.I. Mathew, Colin Brewer
openaire   +3 more sources

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Lancet, The, 2018
Joshua D Lee, Edward V Nunes, Marc Fishman   +2 more
exaly  

Are take‐home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria

Addiction, 2016
Rebecca McDonald, John Strang
exaly  

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis

BMJ, The, 2013
Ziming Xuan, Al Ozonoff, Alexander Y Walley   +2 more
exaly  

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Lancet Neurology, The, 2013
Birgit Högl, Alexander Oksche, Juliane Winkelmann   +2 more
exaly  

A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs

Journal of Addiction Medicine, 2014
Christine M Wilder, Erin L Winstanley
exaly  

Naloxone dosage for opioid reversal: current evidence and clinical implications

Therapeutic Advances in Drug Safety, 2018
Jeffrey Galinkin
exaly